Literature DB >> 27156687

Recent advances in SCF ubiquitin ligase complex: Clinical implications.

Nana Zheng1, Quansheng Zhou1, Zhiwei Wang2, Wenyi Wei3.   

Abstract

F-box proteins, which are subunit recruiting modules of SCF (SKP1-Cullin 1-F-box protein) E3 ligase complexes, play critical roles in the development and progression of human malignancies through governing multiple cellular processes including cell proliferation, apoptosis, invasion and metastasis. Moreover, there are emerging studies that lead to the development of F-box proteins inhibitors with promising therapeutic potential. In this article, we describe how F-box proteins including but not restricted to well-established Fbw7, Skp2 and β-TRCP, are involved in tumorigenesis. However, in-depth investigation is required to further explore the mechanism and the physiological contribution of undetermined F-box proteins in carcinogenesis. Lastly, we suggest that targeting F-box proteins could possibly open new avenues for the treatment and prevention of human cancers.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  F-box protein; Human cancer; Oncoprotein; Tumor suppressor; Ubiquitin

Mesh:

Substances:

Year:  2016        PMID: 27156687      PMCID: PMC4980229          DOI: 10.1016/j.bbcan.2016.05.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  206 in total

1.  Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence.

Authors:  Hui-Kuan Lin; Zhenbang Chen; Guocan Wang; Caterina Nardella; Szu-Wei Lee; Chia-Hsin Chan; Chan-Hsin Chan; Wei-Lei Yang; Jing Wang; Ainara Egia; Keiichi I Nakayama; Carlos Cordon-Cardo; Julie Teruya-Feldstein; Pier Paolo Pandolfi
Journal:  Nature       Date:  2010-03-18       Impact factor: 49.962

Review 2.  Regulation of Skp2 expression and activity and its role in cancer progression.

Authors:  Chia-Hsin Chan; Szu-Wei Lee; Jing Wang; Hui-Kuan Lin
Journal:  ScientificWorldJournal       Date:  2010-06-01

3.  Role of FBXL20 in human colorectal adenocarcinoma.

Authors:  Jianjun Zhu; Kai Li; Lei Dong; Yao Chen
Journal:  Oncol Rep       Date:  2012-09-27       Impact factor: 3.906

4.  SAG/RBX2/ROC2 E3 ubiquitin ligase is essential for vascular and neural development by targeting NF1 for degradation.

Authors:  Mingjia Tan; Yongchao Zhao; Sun-Jung Kim; Margaret Liu; Lijun Jia; Thomas L Saunders; Yuan Zhu; Yi Sun
Journal:  Dev Cell       Date:  2011-11-23       Impact factor: 12.270

5.  Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation.

Authors:  Haojie Huang; Kevin M Regan; Fang Wang; Diping Wang; David I Smith; Jan M A van Deursen; Donald J Tindall
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-24       Impact factor: 11.205

6.  Control of lipid metabolism by phosphorylation-dependent degradation of the SREBP family of transcription factors by SCF(Fbw7).

Authors:  Anders Sundqvist; Maria T Bengoechea-Alonso; Xin Ye; Vasyl Lukiyanchuk; Jianping Jin; J Wade Harper; Johan Ericsson
Journal:  Cell Metab       Date:  2005-06       Impact factor: 27.287

7.  FBH1 protects melanocytes from transformation and is deregulated in melanomas.

Authors:  Yeon-Tae Jeong; Lukas Cermak; Maria V Guijarro; Eva Hernando; Michele Pagano
Journal:  Cell Cycle       Date:  2013-03-06       Impact factor: 4.534

8.  Cks1 is required for tumor cell proliferation but not sufficient to induce hematopoietic malignancies.

Authors:  Susanne Kratzat; Viktoriya Nikolova; Cornelius Miething; Alexander Hoellein; Stephanie Schoeffmann; Oliver Gorka; Elke Pietschmann; Anna-Lena Illert; Jürgen Ruland; Christian Peschel; Jonas Nilsson; Justus Duyster; Ulrich Keller
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

9.  Cytoplasmic Skp2 expression is increased in human melanoma and correlated with patient survival.

Authors:  Guangdi Chen; Yabin Cheng; Zhizhong Zhang; Magdalena Martinka; Gang Li
Journal:  PLoS One       Date:  2011-02-28       Impact factor: 3.240

10.  FBH1 promotes DNA double-strand breakage and apoptosis in response to DNA replication stress.

Authors:  Yeon-Tae Jeong; Mario Rossi; Lukas Cermak; Anita Saraf; Laurence Florens; Michael P Washburn; Patrick Sung; Carl L Schildkraut; Carl Schildkraut; Michele Pagano
Journal:  J Cell Biol       Date:  2013-01-14       Impact factor: 10.539

View more
  49 in total

1.  β-TrCP1 Is a Vacillatory Regulator of Wnt Signaling.

Authors:  Marcus John Long; Hong-Yu Lin; Saba Parvez; Yi Zhao; Jesse Richard Poganik; Paul Huang; Yimon Aye
Journal:  Cell Chem Biol       Date:  2017-07-20       Impact factor: 8.116

2.  De novo variants in FBXO11 cause a syndromic form of intellectual disability with behavioral problems and dysmorphisms.

Authors:  Sandra Jansen; Ilse M van der Werf; A Micheil Innes; Alexandra Afenjar; Pankaj B Agrawal; Ilse J Anderson; Paldeep S Atwal; Ellen van Binsbergen; Marie-José van den Boogaard; Lucia Castiglia; Zeynep H Coban-Akdemir; Anke van Dijck; Diane Doummar; Albertien M van Eerde; Anthonie J van Essen; Koen L van Gassen; Maria J Guillen Sacoto; Mieke M van Haelst; Ivan Iossifov; Jessica L Jackson; Elizabeth Judd; Charu Kaiwar; Boris Keren; Eric W Klee; Jolien S Klein Wassink-Ruiter; Marije E Meuwissen; Kristin G Monaghan; Sonja A de Munnik; Caroline Nava; Charlotte W Ockeloen; Rosa Pettinato; Hilary Racher; Tuula Rinne; Corrado Romano; Victoria R Sanders; Rhonda E Schnur; Eric J Smeets; Alexander P A Stegmann; Asbjørg Stray-Pedersen; David A Sweetser; Paulien A Terhal; Kristian Tveten; Grace E VanNoy; Petra F de Vries; Jessica L Waxler; Marcia Willing; Rolph Pfundt; Joris A Veltman; R Frank Kooy; Lisenka E L M Vissers; Bert B A de Vries
Journal:  Eur J Hum Genet       Date:  2019-01-24       Impact factor: 4.246

Review 3.  Cyclin D degradation by E3 ligases in cancer progression and treatment.

Authors:  Shuo Qie; J Alan Diehl
Journal:  Semin Cancer Biol       Date:  2020-01-30       Impact factor: 15.707

4.  Rottlerin exhibits anti-cancer effect through inactivation of S phase kinase-associated protein 2 in pancreatic cancer cells.

Authors:  Jingna Su; Lixia Wang; Xuyuan Yin; Zhe Zhao; Yingying Hou; Xiantao Ye; Xiuxia Zhou; Zhiwei Wang
Journal:  Am J Cancer Res       Date:  2016-10-01       Impact factor: 6.166

Review 5.  Functional analysis of Cullin 3 E3 ligases in tumorigenesis.

Authors:  Ji Cheng; Jianping Guo; Zhiwei Wang; Brian J North; Kaixiong Tao; Xiangpeng Dai; Wenyi Wei
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-11-08       Impact factor: 10.680

6.  RIPK4 activity in keratinocytes is controlled by the SCFβ-TrCP ubiquitin ligase to maintain cortical actin organization.

Authors:  Giel Tanghe; Corinne Urwyler-Rösselet; Philippe De Groote; Emmanuel Dejardin; Pieter-Jan De Bock; Kris Gevaert; Peter Vandenabeele; Wim Declercq
Journal:  Cell Mol Life Sci       Date:  2018-02-12       Impact factor: 9.261

7.  The E3 Ubiquitin Ligase SCF(Cyclin F) Transmits AKT Signaling to the Cell-Cycle Machinery.

Authors:  Rajarshi Choudhury; Thomas Bonacci; Xianxi Wang; Andrew Truong; Anthony Arceci; Yanqiong Zhang; Christine A Mills; Jennifer L Kernan; Pengda Liu; Michael J Emanuele
Journal:  Cell Rep       Date:  2017-09-26       Impact factor: 9.423

Review 8.  A patent review of the ubiquitin ligase system: 2015-2018.

Authors:  Xin Li; Ekinci Elmira; Sagar Rohondia; Jicang Wang; Jinbao Liu; Q Ping Dou
Journal:  Expert Opin Ther Pat       Date:  2018-11-23       Impact factor: 6.674

9.  A Structure-Based Strategy for Engineering Selective Ubiquitin Variant Inhibitors of Skp1-Cul1-F-Box Ubiquitin Ligases.

Authors:  Maryna Gorelik; Noah Manczyk; Alevtina Pavlenco; Igor Kurinov; Sachdev S Sidhu; Frank Sicheri
Journal:  Structure       Date:  2018-07-19       Impact factor: 5.006

10.  β-Trcp ubiquitin ligase and RSK2 kinase-mediated degradation of FOXN2 promotes tumorigenesis and radioresistance in lung cancer.

Authors:  Jia Ma; Yanwei Lu; Sheng Zhang; Yan Li; Jing Huang; Zhongyuan Yin; Jinghua Ren; Kai Huang; Li Liu; Kunyu Yang; Gang Wu; Shuangbing Xu
Journal:  Cell Death Differ       Date:  2018-02-02       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.